Funder: Breakthrough T1D

Due Dates: July 1, 2025 (FY26 Training Awards) | June 10, 2025 (Genetic Risk/Screening LOIs) | January 10, 2025 (Cell Therapy LOIs) | January 9, 2025 (Autoimmunity Proposals) | October 10, 2024 (Disease-Modifying Therapies LOIs) | October 31, 2024 (Metabolic Therapies LOIs) | November 6, 2024 & May 6, 2025 (Strategic Research LOIs) | Rolling (Conference Awards)

Funding Amounts: Award sizes and durations vary by program; see individual RFAs for specifics. Most awards range from $50,000 to $250,000/year, with some multi-year and larger opportunities.

Summary: Centralized online system for applying to and managing Breakthrough T1D research grants focused on type 1 diabetes prevention, treatment, and cure.

Key Information: Multiple grant mechanisms and deadlines; all applications are managed via the RMS360 portal.